Icon

Qvar Redihaler - (40 mcg/actuation ; Inhalation Aerosol)

Beclomethasone Dipropionate Norton Waterford
40 mcg/actuation ; Inhalation Aerosol
Less Than $1000 mn
Less Than 5
Less Than 5
Less Than 5
None
None None
None
No
Qvar Redihaler Patent 1 Patent 2 Patent 3 Patent 4 Patent 5 Patent 6 Patent 7 Patent 8 Patent 9 Patent 10 Patent 11 Patent 12 Patent 13 Patent 14 Patent 15 Patent 16
***** **** ** *** **, **** **** ** *** **, **** **** ** *** **, **** **** ** *** **, **** **** ** *** **, **** **** ** *** **, **** **** ** *** **, **** **** ** *** **, **** **** ** *** **, **** **** ** *** **, **** **** ** *** **, **** **** ** *** **, **** **** ** *** **, **** **** ** *** **, **** (***** ******) **** ** *** **, **** (***** ****** ******) **** ** *** **, **** (***** ******)
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
***** *** \ ********* *** **, **** ******* **** *** ****** *** ****
  1. *** **, **** : * **** ** ** ***** *** ***** ** *** ***.
  2. *** *, **** : ***** ******** ****** ***** *** **** ** ******.
  3. *** **, **** : ****** **** ***** **** ************ ** ’***, ’***, ’***, ’***, ’***, ’***, ’***, ’***, ’***, ’***, ’***, *** ’***.
  4. *** **, **** : ***** ***** ******** ****** ***** *** **** ** ****** **** '*** *** ***** ****** ****** '***.
  5. *** **, **** : ***** ***** ******** ****** ***** *** **** ** ****** **** ***** ****** ****** '***.
  6. *** *, **** : ****** ***** ******* **** ******* ***** **** ************ ** ****** ** '***, ***** ****** ******* '*** *** '***.
  7. *** **, **** : ***** ***** ******** ****** ***** *** **** ** ****** **** ***** ****** ****** '***.
  8. *** **, **** : ****** ***** ******* **** ******* ***** **** ************ ** ****** ** '***.

Qvar Redihaler - (80 mcg/actuation ; Inhalation Aerosol)

Beclomethasone Dipropionate Norton Waterford
80 mcg/actuation ; Inhalation Aerosol
Less Than $1000 mn
Less Than 5
Less Than 5
Less Than 5
None
None None
None
No
Qvar Redihaler Patent 1 Patent 2 Patent 3 Patent 4 Patent 5 Patent 6 Patent 7 Patent 8 Patent 9 Patent 10 Patent 11 Patent 12 Patent 13 Patent 14 Patent 15 Patent 16
***** **** ** *** **, **** **** ** *** **, **** **** ** *** **, **** **** ** *** **, **** **** ** *** **, **** **** ** *** **, **** **** ** *** **, **** **** ** *** **, **** **** ** *** **, **** **** ** *** **, **** **** ** *** **, **** **** ** *** **, **** **** ** *** **, **** **** ** *** **, **** **** ** *** **, **** **** ** *** **, ****
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
***** *** \ ********* *** **, **** ******* **** *** ****** *** ****
  1. *** **, **** : * **** ** ** ***** *** ***** ** *** ***.
  2. *** **, **** : ***** ******** ****** ***** *** **** ** ******.
  3. *** **, **** : ****** **** ***** **** ************ ** ’***, ’***, ’***, ’***, ’***, ’***, ’***, ’***, ’***, ’***, ’***, ’***, '***, '***, '***, *** '***.
  4. *** **, **** : ***** ***** ******** ****** ***** *** **** ** ****** **** '*** *** ***** ****** ****** '***.
  5. *** **, **** : ***** ***** ******** ****** ***** *** **** ** ****** **** ***** ****** ****** '***.
  6. *** *, **** : ****** ***** ******* **** ******* ***** **** ************ ** ****** ** '***, ***** ****** ******* '*** *** '***.
  7. *** **, **** : ***** ***** ******** ****** ***** *** **** ** ****** **** ***** ****** ****** '***.
  8. *** **, **** : ****** ***** ******* **** ******* ***** **** ************ ** ****** ** '***.

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Drug Name Generic Name Dosage Route of Administration Probable FTF Known Para IV Filers Other ANDA Developers

Please contact contact@researchdelta.com to get more details.